Patients with AD treated with dupilumab have a lower risk of various infections than those treated with methotrexate or cyclosporine.

Dupilumab in combination with other biologic agents is safe and effective for treating various chronic inflammatory conditions.

Patients with atopic dermatitis experienced improvements in severity with 16 weeks of tralokinumab despite the number of ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

Considering dual biologic therapy for psoriasis or eczema? Get a firsthand account of navigating insurance, potential side effects, and treatment outcomes.

Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...